Abstract:Background: Amnestic mild cognitive impairment (aMCI) is a syndrome characterized by significant forgetfulness that does not meet the criteria of dementia. Individuals with aMCI are at greater risk of progressing to dementia. Current studies suggest that good sleep quality is linked with preserved cognition in the elderly, and sleep complaints are common among the elderly with amnesia. Therefore, improving their sleep may be helpful for maintaining and improving their cognitive capacity. According to the theory of traditional Chinese medicine, Yi-Zhi-An-Shen is an herbal compound which may ameliorate forgetfulness and sleep disorders. As growing evidence indicates that the gut microbiome is associated with major mental symptoms, a hypothesis was proposed that Yi-Zhi-An-Shen granules (YZASG) might work by alternating microbial abundance and diversity. In this study, the investigators intend to assess the efficacy of YZASG on global cognition in the elderly suffering from aMCI and evaluate its safety as well as its potential mechanisms via sleep quality, fecal microbial 16S ribosomal DNA and metagenomics analyses, and serum markers. Methods/design: This study is a randomized, double-blind, placebo-controlled clinical trial. A total of 80 patients (aged 60-85 years) will be recruited and allocated randomly to a treatment group and a placebo group in a 1:1 ratio and will then be administered YZASG or isodose placebo three times a day. The intervention course is 16 weeks, with an 18 months follow-up. The primary outcome is the Alzheimer's Disease Assessment Scale-Cognitive Subscale. Secondary outcome measures are the Mini-Mental State Examination, Montreal Cognitive Assessment, Pittsburgh Sleep Quality Index, serum concentrations of immunological factors and inflammatory cytokines, and fecal microbiota. Fecal microbiota will only be collected at the baseline and endpoint of the intervention. Discussion: The results of this trial will be conducive to assessing the safety and effectiveness on cognition of YZASG in intervening aMCI among the elderly and determining if it takes effect via the improvement of sleep quality, regulation of gut microbiota, and concentration of certain serum markers. Trial registration: ClinicalTrials.gov, NCT03601000 . Registered on 26 July 2018.

Follow-up Study on Treatment of Mild Cognitive Impairment by Modified Wuzi Yanzong Granule

[Clinical Study on Treatment of Mild Cognitive Impairment by Modified Wuzi Yanzong Granule].

[Effects of Modified Wuzi Yanzong Granule on Memory Ability and Volume of Hippocampus Measured by MRI in Patients with Mild Cognitive Impairment].

Effect of Modified Wuzi Yanzong Granule on Patients with Mild Cognitive Impairment from Oxidative Damage Aspect.

The Effect of Jiawei Wuzi Yanzong Particle on the Patients with Mild Cognitive Impairment by Neuropsychology and Tomography

Clinical Observation on “peiyuan Yizhi Decoction” in Improving the Memory Quotient of Patients with Mild Cognitive Disorder

Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial

Treatment of Shengqingtongqiao Decoction for mild cognitive impairment of white matter lesions study protocol for a randomized, double-blind, double-dummy, parallel controlled trial

Clinical Efficacy of Wuling Capsules in Treatment of Elderly Patients with Depression and Mild Cognitive Impairment

Clinical Observation on Treatment of Mild Cognitive Impairment by Acupuncture Combined with Jiangzhi Yizhi Granule

Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial

A Two-Year Treatment of Amnestic Mild Cognitive Impairment Using a Compound Chinese Medicine: A Placebo Controlled Randomized Trial

The study of comprehensive intervention effect on mild cognitive impairment in Huzhou

Long-term Efficacy of Chinese Medicine Bushen Capsule on Cognition and Brain Activity in Patients with Amnestic Mild Cognitive Impairment.

[Ginkgo Leaves Tablet Improved the Memory Quotient of Patients with Mild Cognitive Impairment: a Clinical Observation].

The Efficacy of Yangxue Qingnao Granule for Mild Vascular Cognitive Impairment in Senile Patients with Hypertension

Mechanism of Cerebralcare Granule® for Improving Cognitive Function in Resting-State Brain Functional Networks of Sub-healthy Subjects

[Effects of Ginkgo Biloba Tablet in Treating Mild Cognitive Impairment].

The Effects of Ccrc on Cognition and Brain Activity in Amci Patients: A Pilot Placebo Controlled Bold Fmri Study

Effect of Multimodal Intervention in Individuals with Mild Cognitive Impairment: A Randomized Clinical Trial in Shanghai

Monosialotetrahexosy Lganglioside for Vascular Cognitive Impairment: an Efficacy Observation